Passage Bio Q3 EPS $(2.44) Beats $(2.80) Estimate
Benzinga Newsdesk 11 months ago
EarningsEarnings BeatsNews
Passage Bio (NASDAQ:PASG) reported quarterly losses of $(2.44) per share which beat the analyst consensus estimate of $(2.80) by 12.86 percent. This is a 60.33 percent increase over losses of $(6.15) per share from the
Passage Bio (NASDAQ:PASG) reported quarterly losses of $(2.44) per share which beat the analyst consensus estimate of $(2.80) by 12.86 percent. This is a 60.33 percent increase over losses of $(6.15) per share from the same period last year.